<VariationArchive RecordType="classified" VariationID="11635" VariationName="NC_000023.11:g.(74305035_74421492)_(74422068_74520989)del" VariationType="Deletion" Accession="VCV000011635" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2017-06-20" MostRecentSubmission="2017-06-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26674" VariationID="11635">
      <GeneList>
        <Gene Symbol="LOC130068443" FullName="ATAC-STARR-seq lymphoblastoid active region 29766" GeneID="130068443" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74510721" stop="74510770" display_start="74510721" display_stop="74510770" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SLC16A2" FullName="solute carrier family 16 member 2" GeneID="6567" HGNC_ID="HGNC:10923" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74421493" stop="74533916" display_start="74421493" display_stop="74533916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73641327" stop="73753763" display_start="73641327" display_stop="73753763" Strand="+" />
          </Location>
          <OMIM>300095</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(74305035_74421492)_(74422068_74520989)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" outerStart="74305035" innerStart="74421492" innerStop="74422068" outerStop="74520989" display_start="74305035" display_stop="74520989" variantLength="215955" />
      </Location>
      <OtherNameList>
        <Name>EX1DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(74305035_74421492)_(74422068_74520989)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(74305035_74421492)_(74422068_74520989)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300095.0004" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 300095.0004 based on the description that the deletion included exon 1 but no other gene.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(74305035_74421492)_(74422068_74520989)del AND Allan-Herndon-Dudley syndrome" Accession="RCV000012401" Version="25">
        <ClassifiedConditionList TraitSetID="3177">
          <ClassifiedCondition DB="MedGen" ID="C0795889">Allan-Herndon-Dudley syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-06-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-06-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-06-20" MostRecentSubmission="2017-06-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12871948</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Allan-Herndon syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Monocarboxylate transporter-8 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Triiodothyronine resistence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 resisitence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation with hypotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation and muscular atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TRIIODOTHYRONINE RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Allan-Herndon-Dudley syndrome</ElementValue>
                <XRef ID="Allan-Herndon-Dudley+Syndrome/306" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010354" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AHDS</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Allan-Herndon-Dudley syndrome (AHDS), an X-linked disorder, is characterized in males by neurologic findings (hypotonia and feeding difficulties in infancy, developmental delayÂ / intellectual disability ranging from mild to profound) and later-onset pyramidal signs, extrapyramidal findings (dystonia, choreoathetosis, paroxysmal movement disorder, hypokinesia, masked facies), and seizures, often with drug resistance. Additional findings can include dysthyroidism (manifest as poor weight gain, reduced muscle mass, and variable cold intolerance, sweating, elevated heart rate, and irritability) and pathognomonic thyroid test results. Most heterozygous females are not clinically affected but may have minor thyroid test abnormalities.</Attribute>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5617" />
                <XRef ID="5617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301789</ID>
                <ID Source="BookShelf">NBK26373</ID>
              </Citation>
              <XRef ID="59" DB="Orphanet" />
              <XRef ID="C0795889" DB="MedGen" />
              <XRef ID="MONDO:0010354" DB="MONDO" />
              <XRef Type="MIM" ID="300523" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32635" SubmissionDate="2017-06-15" DateLastUpdated="2017-06-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300095.0004_ALLAN-HERNDON-DUDLEY SYNDROME" title="SLC16A2, EX1DEL_ALLAN-HERNDON-DUDLEY SYNDROME" />
        <ClinVarAccession Accession="SCV000032635" DateUpdated="2017-06-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with elevated serum T3 and severe mental retardation (AHDS; 300523), Friesema et al. (2003) found complete absence of exon 1 of the MCT8 gene. Analysis of the size of the deletion of the X chromosome in this patient excluded the involvement of other genes.</Attribute>
              <Citation>
                <ID Source="PubMed">12871948</ID>
              </Citation>
              <XRef DB="OMIM" ID="300523" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC16A2" />
          </GeneList>
          <Name>SLC16A2, EX1DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX1DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300095.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALLAN-HERNDON-DUDLEY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32635" TraitType="Disease" MappingType="Name" MappingValue="ALLAN-HERNDON-DUDLEY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0795889" Name="Allan-Herndon-Dudley syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

